The hypothesis that infection with Proteus is associated with rheumatoid arthritis (RA), whereas ankylosing spondylitis is related to Kiebsiella Let us examine first the similarity in amino acid sequence between the third hypervariable region of RA associated major histocompatibility complex alleles (e.g. DRB1*0401, 0404, 0101) and Proteus mirabilis haemolysin; the sequences in questions are EQR(or K)RAA and ESRRAL, respectively. Not surprisingly, given their degree of similarity, the ESRRAL peptide can be modelled in a conformation similar to that taken up by the HIA-DR peptide in an intact DR molecule (paper in this issue by Wilson et ad). Its structure within the haemolysin is unknown, but would need to be similar if the haemolysin is really the bacterial antigen responsible for inducing cross reactive antibodies. RA patients had higher titres of antibodies to the haemolysin peptide than did controls (though, again, age matching was conspicuously absent), so in theory these antibodies should also react with the HLA-DR peptide. Indeed, they should be absorbed out by reaction with either intact haemolysin or HLA-DR. Likewise, if the haemolysin is the crucial antigen accounting for the higher titres of antibodies to whole Proteus bacteria, this reactivity should be. abolished by absorption of sera with peptides or haemolysin. Furthermore, the activity of DR4 sera against Proteus, or indeed the same cross reactivity shown by rabbit anti-DR4 antisera, should be abolished by absorption with specific peptide. None of these points has been established, making it difficult to be confident of any relationship between the various findings. Indeed 
